nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—CYP1A2—Thalidomide—leprosy	0.282	0.508	CbGbCtD
Tizanidine—CYP1A2—Rifampicin—leprosy	0.273	0.492	CbGbCtD
Tizanidine—NISCH—Menadione—Thalidomide—leprosy	0.018	1	CbGdCrCtD
Tizanidine—Suicide attempt—Dapsone—leprosy	0.0128	0.03	CcSEcCtD
Tizanidine—Hypoproteinaemia—Thalidomide—leprosy	0.0127	0.0297	CcSEcCtD
Tizanidine—Albuminuria—Dapsone—leprosy	0.00973	0.0228	CcSEcCtD
Tizanidine—Dementia—Thalidomide—leprosy	0.00907	0.0213	CcSEcCtD
Tizanidine—Foetor hepaticus—Thalidomide—leprosy	0.00656	0.0154	CcSEcCtD
Tizanidine—Suicide attempt—Thalidomide—leprosy	0.00656	0.0154	CcSEcCtD
Tizanidine—Myasthenia—Thalidomide—leprosy	0.00592	0.0139	CcSEcCtD
Tizanidine—Hypothyroidism—Thalidomide—leprosy	0.0058	0.0136	CcSEcCtD
Tizanidine—Intestinal obstruction—Thalidomide—leprosy	0.00546	0.0128	CcSEcCtD
Tizanidine—Liver disorder—Thalidomide—leprosy	0.00546	0.0128	CcSEcCtD
Tizanidine—Neuralgia—Thalidomide—leprosy	0.00535	0.0126	CcSEcCtD
Tizanidine—Metrorrhagia—Thalidomide—leprosy	0.00521	0.0122	CcSEcCtD
Tizanidine—Hyperlipidaemia—Thalidomide—leprosy	0.00516	0.0121	CcSEcCtD
Tizanidine—Psychotic disorder—Dapsone—leprosy	0.00515	0.0121	CcSEcCtD
Tizanidine—Stupor—Thalidomide—leprosy	0.00498	0.0117	CcSEcCtD
Tizanidine—Albuminuria—Thalidomide—leprosy	0.00498	0.0117	CcSEcCtD
Tizanidine—Amblyopia—Thalidomide—leprosy	0.00482	0.0113	CcSEcCtD
Tizanidine—Skin ulcer—Thalidomide—leprosy	0.00478	0.0112	CcSEcCtD
Tizanidine—Muscular weakness—Dapsone—leprosy	0.00465	0.0109	CcSEcCtD
Tizanidine—Influenza—Dapsone—leprosy	0.00456	0.0107	CcSEcCtD
Tizanidine—Petechiae—Thalidomide—leprosy	0.00452	0.0106	CcSEcCtD
Tizanidine—Cellulitis—Thalidomide—leprosy	0.00409	0.0096	CcSEcCtD
Tizanidine—Thinking abnormal—Thalidomide—leprosy	0.00406	0.00953	CcSEcCtD
Tizanidine—Herpes simplex—Thalidomide—leprosy	0.00404	0.00947	CcSEcCtD
Tizanidine—Neuropathy peripheral—Dapsone—leprosy	0.00398	0.00935	CcSEcCtD
Tizanidine—Dyskinesia—Thalidomide—leprosy	0.00396	0.00929	CcSEcCtD
Tizanidine—Leukocytosis—Thalidomide—leprosy	0.00396	0.00929	CcSEcCtD
Tizanidine—Hypercholesterolaemia—Thalidomide—leprosy	0.00393	0.00923	CcSEcCtD
Tizanidine—Sinusitis—Dapsone—leprosy	0.00381	0.00895	CcSEcCtD
Tizanidine—Neck pain—Thalidomide—leprosy	0.00377	0.00883	CcSEcCtD
Tizanidine—Pulmonary embolism—Thalidomide—leprosy	0.00372	0.00873	CcSEcCtD
Tizanidine—Hepatocellular injury—Thalidomide—leprosy	0.00372	0.00873	CcSEcCtD
Tizanidine—Pharyngitis—Dapsone—leprosy	0.00362	0.0085	CcSEcCtD
Tizanidine—Depressed level of consciousness—Thalidomide—leprosy	0.00359	0.00843	CcSEcCtD
Tizanidine—Candida infection—Thalidomide—leprosy	0.00355	0.00833	CcSEcCtD
Tizanidine—Neuropathy—Thalidomide—leprosy	0.00349	0.00819	CcSEcCtD
Tizanidine—Tinnitus—Dapsone—leprosy	0.0034	0.00798	CcSEcCtD
Tizanidine—Pulmonary oedema—Thalidomide—leprosy	0.00331	0.00777	CcSEcCtD
Tizanidine—Hypertonia—Thalidomide—leprosy	0.00326	0.00765	CcSEcCtD
Tizanidine—Mental disability—Thalidomide—leprosy	0.00323	0.00757	CcSEcCtD
Tizanidine—Sepsis—Thalidomide—leprosy	0.00323	0.00757	CcSEcCtD
Tizanidine—Euphoric mood—Thalidomide—leprosy	0.0032	0.0075	CcSEcCtD
Tizanidine—Gastroenteritis—Thalidomide—leprosy	0.00305	0.00715	CcSEcCtD
Tizanidine—Vascular purpura—Thalidomide—leprosy	0.00302	0.00708	CcSEcCtD
Tizanidine—Deafness—Thalidomide—leprosy	0.00302	0.00708	CcSEcCtD
Tizanidine—Vision blurred—Dapsone—leprosy	0.00299	0.00702	CcSEcCtD
Tizanidine—Eye pain—Thalidomide—leprosy	0.00299	0.00702	CcSEcCtD
Tizanidine—Renal failure acute—Thalidomide—leprosy	0.00292	0.00686	CcSEcCtD
Tizanidine—Dermatitis exfoliative—Thalidomide—leprosy	0.00286	0.00671	CcSEcCtD
Tizanidine—Vertigo—Dapsone—leprosy	0.00285	0.00669	CcSEcCtD
Tizanidine—Purpura—Thalidomide—leprosy	0.0028	0.00657	CcSEcCtD
Tizanidine—Arthritis—Thalidomide—leprosy	0.00278	0.00652	CcSEcCtD
Tizanidine—Cardiac failure—Thalidomide—leprosy	0.00277	0.00649	CcSEcCtD
Tizanidine—Cerebrovascular accident—Thalidomide—leprosy	0.00276	0.00646	CcSEcCtD
Tizanidine—Hyponatraemia—Thalidomide—leprosy	0.00271	0.00636	CcSEcCtD
Tizanidine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.0027	0.00633	CcSEcCtD
Tizanidine—Affect lability—Thalidomide—leprosy	0.00266	0.00623	CcSEcCtD
Tizanidine—Migraine—Thalidomide—leprosy	0.00266	0.00623	CcSEcCtD
Tizanidine—Psychotic disorder—Thalidomide—leprosy	0.00264	0.00619	CcSEcCtD
Tizanidine—Cardiac arrest—Thalidomide—leprosy	0.00257	0.00602	CcSEcCtD
Tizanidine—Mood swings—Thalidomide—leprosy	0.00256	0.006	CcSEcCtD
Tizanidine—Tachycardia—Dapsone—leprosy	0.00253	0.00594	CcSEcCtD
Tizanidine—Liver function test abnormal—Thalidomide—leprosy	0.00249	0.00585	CcSEcCtD
Tizanidine—Dry skin—Thalidomide—leprosy	0.00248	0.00581	CcSEcCtD
Tizanidine—Orthostatic hypotension—Thalidomide—leprosy	0.00247	0.00579	CcSEcCtD
Tizanidine—Hypokalaemia—Thalidomide—leprosy	0.00246	0.00576	CcSEcCtD
Tizanidine—Muscular weakness—Thalidomide—leprosy	0.00238	0.00559	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Thalidomide—leprosy	0.00238	0.00559	CcSEcCtD
Tizanidine—Influenza—Thalidomide—leprosy	0.00233	0.00547	CcSEcCtD
Tizanidine—Dysphagia—Thalidomide—leprosy	0.00233	0.00547	CcSEcCtD
Tizanidine—Angina pectoris—Thalidomide—leprosy	0.00227	0.00533	CcSEcCtD
Tizanidine—Bronchitis—Thalidomide—leprosy	0.00224	0.00527	CcSEcCtD
Tizanidine—Pollakiuria—Thalidomide—leprosy	0.00216	0.00506	CcSEcCtD
Tizanidine—Gastrointestinal pain—Dapsone—leprosy	0.00212	0.00497	CcSEcCtD
Tizanidine—Weight decreased—Thalidomide—leprosy	0.00211	0.00495	CcSEcCtD
Tizanidine—Hyperglycaemia—Thalidomide—leprosy	0.00211	0.00494	CcSEcCtD
Tizanidine—Pneumonia—Thalidomide—leprosy	0.00209	0.00491	CcSEcCtD
Tizanidine—Drowsiness—Thalidomide—leprosy	0.00208	0.00488	CcSEcCtD
Tizanidine—Depression—Thalidomide—leprosy	0.00208	0.00487	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00206	0.00484	CcSEcCtD
Tizanidine—Acute coronary syndrome—Thalidomide—leprosy	0.00205	0.00481	CcSEcCtD
Tizanidine—Abdominal pain—Dapsone—leprosy	0.00205	0.00481	CcSEcCtD
Tizanidine—Body temperature increased—Dapsone—leprosy	0.00205	0.00481	CcSEcCtD
Tizanidine—Renal failure—Thalidomide—leprosy	0.00205	0.0048	CcSEcCtD
Tizanidine—Myocardial infarction—Thalidomide—leprosy	0.00204	0.00478	CcSEcCtD
Tizanidine—Neuropathy peripheral—Thalidomide—leprosy	0.00204	0.00478	CcSEcCtD
Tizanidine—Conjunctivitis—Thalidomide—leprosy	0.00202	0.00474	CcSEcCtD
Tizanidine—Sweating—Thalidomide—leprosy	0.002	0.00468	CcSEcCtD
Tizanidine—Haematuria—Thalidomide—leprosy	0.00198	0.00465	CcSEcCtD
Tizanidine—Sinusitis—Thalidomide—leprosy	0.00195	0.00458	CcSEcCtD
Tizanidine—Agranulocytosis—Thalidomide—leprosy	0.00194	0.00456	CcSEcCtD
Tizanidine—Bradycardia—Thalidomide—leprosy	0.0019	0.00446	CcSEcCtD
Tizanidine—Rhinitis—Thalidomide—leprosy	0.00187	0.00439	CcSEcCtD
Tizanidine—Hepatitis—Thalidomide—leprosy	0.00187	0.00438	CcSEcCtD
Tizanidine—Pharyngitis—Thalidomide—leprosy	0.00185	0.00435	CcSEcCtD
Tizanidine—Urinary tract disorder—Thalidomide—leprosy	0.00184	0.00433	CcSEcCtD
Tizanidine—Urethral disorder—Thalidomide—leprosy	0.00183	0.0043	CcSEcCtD
Tizanidine—Erythema multiforme—Thalidomide—leprosy	0.00177	0.00414	CcSEcCtD
Tizanidine—Tinnitus—Thalidomide—leprosy	0.00174	0.00409	CcSEcCtD
Tizanidine—Cardiac disorder—Thalidomide—leprosy	0.00173	0.00407	CcSEcCtD
Tizanidine—Angiopathy—Thalidomide—leprosy	0.00169	0.00398	CcSEcCtD
Tizanidine—Immune system disorder—Thalidomide—leprosy	0.00169	0.00396	CcSEcCtD
Tizanidine—Mediastinal disorder—Thalidomide—leprosy	0.00168	0.00395	CcSEcCtD
Tizanidine—Arrhythmia—Thalidomide—leprosy	0.00167	0.00391	CcSEcCtD
Tizanidine—Alopecia—Thalidomide—leprosy	0.00165	0.00387	CcSEcCtD
Tizanidine—Vomiting—Dapsone—leprosy	0.00165	0.00387	CcSEcCtD
Tizanidine—Mental disorder—Thalidomide—leprosy	0.00164	0.00384	CcSEcCtD
Tizanidine—Flatulence—Thalidomide—leprosy	0.0016	0.00376	CcSEcCtD
Tizanidine—Tension—Thalidomide—leprosy	0.0016	0.00374	CcSEcCtD
Tizanidine—Nervousness—Thalidomide—leprosy	0.00158	0.0037	CcSEcCtD
Tizanidine—Back pain—Thalidomide—leprosy	0.00157	0.00369	CcSEcCtD
Tizanidine—Muscle spasms—Thalidomide—leprosy	0.00156	0.00367	CcSEcCtD
Tizanidine—Nausea—Dapsone—leprosy	0.00154	0.00361	CcSEcCtD
Tizanidine—Vision blurred—Thalidomide—leprosy	0.00153	0.0036	CcSEcCtD
Tizanidine—Tremor—Thalidomide—leprosy	0.00152	0.00357	CcSEcCtD
Tizanidine—Ill-defined disorder—Thalidomide—leprosy	0.00151	0.00354	CcSEcCtD
Tizanidine—Anaemia—Thalidomide—leprosy	0.0015	0.00353	CcSEcCtD
Tizanidine—Agitation—Thalidomide—leprosy	0.00149	0.00351	CcSEcCtD
Tizanidine—Malaise—Thalidomide—leprosy	0.00147	0.00344	CcSEcCtD
Tizanidine—Vertigo—Thalidomide—leprosy	0.00146	0.00343	CcSEcCtD
Tizanidine—Syncope—Thalidomide—leprosy	0.00146	0.00342	CcSEcCtD
Tizanidine—Leukopenia—Thalidomide—leprosy	0.00146	0.00341	CcSEcCtD
Tizanidine—Loss of consciousness—Thalidomide—leprosy	0.00143	0.00335	CcSEcCtD
Tizanidine—Convulsion—Thalidomide—leprosy	0.00141	0.00331	CcSEcCtD
Tizanidine—Hypertension—Thalidomide—leprosy	0.0014	0.00329	CcSEcCtD
Tizanidine—Arthralgia—Thalidomide—leprosy	0.00138	0.00325	CcSEcCtD
Tizanidine—Anxiety—Thalidomide—leprosy	0.00138	0.00324	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00137	0.00323	CcSEcCtD
Tizanidine—Discomfort—Thalidomide—leprosy	0.00137	0.00321	CcSEcCtD
Tizanidine—Dry mouth—Thalidomide—leprosy	0.00135	0.00318	CcSEcCtD
Tizanidine—Confusional state—Thalidomide—leprosy	0.00134	0.00314	CcSEcCtD
Tizanidine—Oedema—Thalidomide—leprosy	0.00133	0.00311	CcSEcCtD
Tizanidine—Infection—Thalidomide—leprosy	0.00132	0.00309	CcSEcCtD
Tizanidine—Shock—Thalidomide—leprosy	0.00131	0.00306	CcSEcCtD
Tizanidine—Nervous system disorder—Thalidomide—leprosy	0.0013	0.00305	CcSEcCtD
Tizanidine—Thrombocytopenia—Thalidomide—leprosy	0.0013	0.00305	CcSEcCtD
Tizanidine—Tachycardia—Thalidomide—leprosy	0.0013	0.00304	CcSEcCtD
Tizanidine—Skin disorder—Thalidomide—leprosy	0.00129	0.00302	CcSEcCtD
Tizanidine—Hyperhidrosis—Thalidomide—leprosy	0.00128	0.00301	CcSEcCtD
Tizanidine—Hypotension—Thalidomide—leprosy	0.00124	0.00291	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Thalidomide—leprosy	0.00121	0.00284	CcSEcCtD
Tizanidine—Paraesthesia—Thalidomide—leprosy	0.00119	0.0028	CcSEcCtD
Tizanidine—Dyspnoea—Thalidomide—leprosy	0.00118	0.00278	CcSEcCtD
Tizanidine—Somnolence—Thalidomide—leprosy	0.00118	0.00277	CcSEcCtD
Tizanidine—Dyspepsia—Thalidomide—leprosy	0.00117	0.00274	CcSEcCtD
Tizanidine—Fatigue—Thalidomide—leprosy	0.00114	0.00268	CcSEcCtD
Tizanidine—Constipation—Thalidomide—leprosy	0.00113	0.00266	CcSEcCtD
Tizanidine—Feeling abnormal—Thalidomide—leprosy	0.00109	0.00257	CcSEcCtD
Tizanidine—Gastrointestinal pain—Thalidomide—leprosy	0.00109	0.00255	CcSEcCtD
Tizanidine—Urticaria—Thalidomide—leprosy	0.00105	0.00247	CcSEcCtD
Tizanidine—Abdominal pain—Thalidomide—leprosy	0.00105	0.00246	CcSEcCtD
Tizanidine—Body temperature increased—Thalidomide—leprosy	0.00105	0.00246	CcSEcCtD
Tizanidine—Hypersensitivity—Thalidomide—leprosy	0.000978	0.00229	CcSEcCtD
Tizanidine—Asthenia—Thalidomide—leprosy	0.000952	0.00223	CcSEcCtD
Tizanidine—Pruritus—Thalidomide—leprosy	0.000939	0.0022	CcSEcCtD
Tizanidine—Diarrhoea—Thalidomide—leprosy	0.000908	0.00213	CcSEcCtD
Tizanidine—Dizziness—Thalidomide—leprosy	0.000878	0.00206	CcSEcCtD
Tizanidine—Vomiting—Thalidomide—leprosy	0.000844	0.00198	CcSEcCtD
Tizanidine—Rash—Thalidomide—leprosy	0.000837	0.00196	CcSEcCtD
Tizanidine—Dermatitis—Thalidomide—leprosy	0.000836	0.00196	CcSEcCtD
Tizanidine—Nausea—Thalidomide—leprosy	0.000788	0.00185	CcSEcCtD
